Clinical trial
Pazopanib in Molecularly Selected Patients With Advanced NSCLC
NCT02193152
Study timeline
Study start (actual)2015-04-27Date precision: day
Registry last updated2020-07-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Non-Small Cell Lungunresolved
Non-Small Cell Lung Cancerunresolved
Nonsmall Cell Lung Cancerunresolved
Interventions
PazopanibDRUG · verified · RxNorm: pazopanib
Sponsors & collaborators
Washington University School of Medicinelead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02193152 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.